SCHEDULE 13G/A: Altium Entities Disclose 0.27% Passive Stake in SRx Health Solutions
Beneficial Ownership Disclosure
Altium Capital Management LLC and its affiliated entities have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 0.27% in SRx Health Solutions, Inc.
Summary
- Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP, and Altium Healthcare Long Short GP LLC jointly filed an Amendment No. 3 to Schedule 13G.
- The filing reports beneficial ownership in SRx Health Solutions, Inc.'s Common Stock, $0.001 par value.
- As of March 31, 2025, the reporting persons collectively beneficially own 38,984 shares of SRx Health Solutions, Inc. Common Stock.
- This ownership represents 0.27% of the Issuer's outstanding Common Stock.
- The percentage is based on 14,301,529 shares of Common Stock outstanding as of March 25, 2025, as reported in the Issuer's Form 8-K filed on May 31, 2025.
- The reporting persons have shared voting power and shared dispositive power over all 38,984 shares.
- The securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of passive beneficial ownership by an investment firm in a publicly traded company. It does not provide specific insights into broader industry trends or competitive positioning beyond the fact that an investment entity holds a minor stake in a healthcare solutions company.
Stakeholder Impact
- Shareholders: Provides transparency regarding a passive ownership stake by an institutional investor, which is a routine disclosure and unlikely to have significant direct impact given the small percentage.
Key Dates
| Date | Description |
|---|---|
| 03/25/2025 | Date of outstanding shares calculation for SRx Health Solutions, Inc. (14,301,529 shares). |
| 03/31/2025 | Date of event which requires the filing of this Schedule 13G statement. |
| 05/15/2025 | Date of signing and filing of the Schedule 13G Amendment No. 3. |
| 05/31/2025 | Date of Issuer's Form 8-K filing with the SEC, which provided the outstanding shares count. |
Keywords
Schedule 13G, beneficial ownership, SRx Health Solutions, Altium Capital Management, Common Stock, SEC filing, investment adviser, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.